The combination of an inflammatory peripheral blood gene expression and imaging biomarkers enhance prediction of radiographic progression in knee osteoarthritis
Autor: | Gregory Chang, Pamela Rosenthal, Svetlana Krasnokutsky, Jenny T. Bencardino, Hua Zhou, Mukundan Attur, Leon Rybak, Janet L. Huebner, Virginia B. Kraus, Steven B. Abramson, Jonathan Samuels |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Oncology
medicine.medical_specialty lcsh:Diseases of the musculoskeletal system Radiographic progression Knee Joint Population Gene Expression Osteoarthritis Meniscus (anatomy) 03 medical and health sciences 0302 clinical medicine Bone marrow lesion Internal medicine medicine Humans Inflammatory gene expression 030212 general & internal medicine education 030203 arthritis & rheumatology Molecular biomarkers education.field_of_study medicine.diagnostic_test Receiver operating characteristic business.industry Magnetic resonance imaging Odds ratio Joint space narrowing Osteoarthritis Knee medicine.disease Magnetic Resonance Imaging Rheumatology medicine.anatomical_structure Disease Progression Biomarker (medicine) lcsh:RC925-935 business Biomarkers Research Article |
Zdroj: | Arthritis Research & Therapy Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-17 (2020) |
ISSN: | 1478-6362 1478-6354 |
Popis: | Objective Predictive biomarkers of progression in knee osteoarthritis are sought to enable clinical trials of structure-modifying drugs. A peripheral blood leukocyte (PBL) inflammatory gene signature, MRI-based bone marrow lesions (BML) and meniscus extrusion scores, meniscal lesions, and osteophytes on X-ray each have been shown separately to predict radiographic joint space narrowing (JSN) in subjects with symptomatic knee osteoarthritis (SKOA). In these studies, we determined whether the combination of the PBL inflammatory gene expression and these imaging findings at baseline enhanced the prognostic value of either alone. Methods PBL inflammatory gene expression (increased mRNA for IL-1β, TNFα, and COX-2), routine radiographs, and 3T knee MRI were assessed in two independent populations with SKOA: an NYU cohort and the Osteoarthritis Initiative (OAI). At baseline and 24 months, subjects underwent standardized fixed-flexion knee radiographs and knee MRI. Medial JSN (mJSN) was determined as the change in medial JSW. Progressors were defined by an mJSN cut-point (≥ 0.5 mm/24 months). Models were evaluated by odds ratios (OR) and area under the receiver operating characteristic curve (AUC). Results We validated our prior finding in these two independent (NYU and OAI) cohorts, individually and combined, that an inflammatory PBL inflammatory gene expression predicted radiographic progression of SKOA after adjustment for age, sex, and BMI. Similarly, the presence of baseline BML and meniscal lesions by MRI or semiquantitative osteophyte score on X-ray each predicted radiographic medial JSN at 24 months. The combination of the PBL inflammatory gene expression and medial BML increased the AUC from 0.66 (p = 0.004) to 0.75 (p p Conclusion The use of the PBL inflammatory gene expression together with imaging biomarkers as combinatorial predictive biomarkers, markedly enhances the identification of radiographic progressors. The identification of the SKOA population at risk for progression will help in the future design of disease-modifying OA drug trials and personalized medicine strategies. |
Databáze: | OpenAIRE |
Externí odkaz: |